Упрощенная HTML-версия
162
ЛІТЕРАТУРА
1.
Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy. The
Society of Obstetricians and Gynaecologists of Canada (SOGC) Journal of Obstetrics and
Gynaecology Canada, Volume 30, Number 3, March 2008. Supplement 1, 52 pages.
2.
Bendon RW, Hayden LE, Hurtubise PE, Getahun B, Siddiqi TA, Glueck HI, et al. Prenatal
screening for anticardiolipin antibody. Am J Perinatol 1990;7:245-50.
3.
Parry S, Macones GA, Roth NW, Desperito TJ, Marzullo A, Morgan MA. Antiphospholipid
antibodies in chronic hypertension: the value of screening during pregnancy. Am J Perinatol
1998;15:527-31.
4.
Salomon O, Seligsohn U, Steinberg DM, Zalel Y, Lerner A, Rosenberg N, et al. The common
prothrombotic factors in nulliparous women do not compromise blood flow in the feto-
maternal circulation and are not associated with preeclampsia or intrauterine growth
restriction. Am J Obstet Gynecol 2004;191:2002-9.
5.
Steegers-Theunissen RP, Van Iersel CA, Peer PG, Nelen WL, Steegers EA.
Hyperhomocysteinemia, pregnancy complications, and the timing of investigation. Obstet
Gynecol 2004;104:336-43.
6.
Rigo J Jr, Boze T, Derzsy Z, Derzbach L, Treszl A, Lazar L, et al. Family history of early-onset
cardiovascular disorders is associated with a higher risk of severe preeclampsia. Eur J Obstet
Gynecol Reprod Biol 2006.
7.
Milne F, Redman C, Walker J, Baker P, Bradley J, Cooper C, et al. The pre-eclampsia
community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the
community. BMJ 2005;330:576-80.
8.
Friedman SA, Lindheimer MD. Prediction and differential diagnosis. In: Lindheimer MD,
Roberts JM, Cunningham GC, eds. Chesley’s hypertensive disorders in pregnancy. Stanford:
Appleton and Lange; 1999:201-27.
9.
Dugoff L, Hobbins JC, Malone FD, Porter TF, Luthy D, Comstock CH, et al. First-trimester
maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations
and nuchal translucency are associated with obstetric complications: a population-based
screening study (the FASTER Trial). Am J Obstet Gynecol 2004;191:1446-51.
10. Audibert F, Benchimol Y, Benattar C, Champagne C, Frydman R. Prediction of preeclampsia
or intrauterine growth restriction by second trimester serum screening and uterine Doppler
velocimetry. Fetal Diagn Ther 2005;20:48-53.
11. Benn PA, Horne D, Briganti S, Rodis JF, Clive JM. Elevated second-trimester maternal serum
hCG alone or in combination with elevated alpha-fetoprotein. Obstet Gynecol 1996;87:217-
22.
12. Dugoff L, Hobbins JC, Malone FD, Vidaver J, Sullivan L, Canick JA, et al. Quad screen as a
predictor of adverse pregnancy outcome. Obstet Gynecol 2005;106:260-7.
13. Hershkovitz R, de SM, Kingdom J. Mid-trimester placentation assessment in high-risk
pregnancies using maternal serum screening and uterine artery Doppler. Hypertens
Pregnancy 2005;24:273-80.
14. Konchak PS, Bernstein IM, Capeless EL. Uterine artery Doppler velocimetry in the detection
of adverse obstetric outcomes in women with unexplained elevated maternal serum alpha-
fetoprotein levels. Am J Obstet Gynecol 1995;173:1115-9.
15. Waller DK, Lustig LS, Cunningham GC, Feuchtbaum LB, Hook EB. The association between
maternal serum alpha-fetoprotein and preterm birth, small for gestational age infants,
preeclampsia, and placental complications. Obstet Gynecol 1996;88:816-22.
16. Towner D, Gandhi S, El KD. Obstetric outcomes in women with elevated maternal serum
human chorionic gonadotropin. Am J Obstet Gynecol 2006;194(6):1676-81.
17. Aquilina J, Barnett A, Thompson O, Harrington K. Second-trimester maternal serum inhibin A
concentration as an early marker for preeclampsia. Am J Obstet Gynecol 1999;181:131-6.
18. Grobman WA,Wang EY. Serum levels of activin A and inhibin A and the subsequent
development of preeclampsia. Obstet Gynecol 2000;96:390-4.
19. Lambert-Messerlian GM, Silver HM, Petraglia F, Luisi S, Pezzani I, Maybruck WM, et al.
Second-trimester levels of maternal serum human chorionic gonadotropin and inhibin a as
predictors of preeclampsia in the third trimester of pregnancy. J Soc Gynecol Investig
2000;7:170-4.